Home › Bone Cancer › NCT06720142

Mg OSTEOCRETE Post-Treatment Outcomes

Clinical and Radiographic Outcomes of Patients Treated With Mg OSTEOCRETE

Who can join

Ages 18 and older · All sexes

Inclusion Criteria:

* 18 years of age and older on the day of surgery
* has received or will receive Mg OSTEOCRETE as a component of their treatment at this institution in accordance with Instructions for Use for the implanted product
* Mg OSTEOCRETE is indicated for one of the following reasons:

  1. as a bone void filler following bone tumor resection, or;
  2. as an augment for defects causing aseptic loosening of orthopaedic implants, or;
  3. to help substitute bone for trauma-related conditions

Exclusion Criteria:

* any contraindication as per Instructions for Use for Mg OSTEOCRETE

About the study

Mg OSTEOCRETE is a bone substitute used to fill a defect in bone caused by excision of a tumor, orthopaedic hardware that has become loosened, or a trauma-related condition. The aim of this study is to determine the amount of time it takes for bone to heal after treatment with Mg OSTEOCRETE, and to better understand the efficacy of this treatment through clinical and patient-reported outcomes.

What is being tested

• Mg OSTEOCRETE as a bone void filler (device)
• Mg OSTEOCRETE as a bone void filler (device)
• Mg OSTEOCRETE as a bone void filler (device)

Sponsor: Santiago Lozano-Calderon · Participants: 10 · Started: Mar 17, 2025

Contact the study team

• Shreya Halur, BS · Phone: 617-726-4932
• Santiago A Lozano-Calderon, MD, PhD · Phone: 617-643-4947

Official record on ClinicalTrials.gov — NCT06720142

Locations in the U.S.

Conditions

• Bone Cancer

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.